Does the classic 'clavicular pinch' risk apply to axillary-access pacemaker leads?

Largely no. Classical subclavian crush syndrome occurs with medial subclavian puncture, where the lead is compressed between the clavicle and first rib. Axillary venous access enters the vein lateral to the costoclavicular ligament, bypassing this high-pressure pinch point. The leads still traverse the shoulder girdle, but the dominant crush mechanism is mitigated.

How long does it take a transvenous pacemaker pocket and leads to mature?

The pectoral pocket and lead-tissue interface require approximately 6 to 8 weeks for initial fibrotic stabilization. Septal LBBAP leads, anchored by helix into the interventricular septum, carry a higher early-phase macro-dislodgement risk than mature leads encased in scar tissue. Vigorous ipsilateral arm activity is highest-risk during this window.

Is rowing safe after a transvenous LBBAP pacemaker implant?

It depends on time since implant, lead stability on interrogation, pacing dependence, and exertion intensity. The catch phase loads the pectoralis on the implant side bilaterally and symmetrically, which is more concerning during pocket healing than long-term. Sustained ipsilateral arm work also raises the question of effort-induced axillary venous thrombosis (Paget-Schroetter physiology) given two leads in the vein. Device-informed clearance from the implanting electrophysiologist is essential.

What is the bigger concern: rowing or lifting a 32-pound boat?

The 32-pound (14.5 kg) boat lift, especially as an overhead or front-loaded carry on the implant side, presents a greater acute mechanical risk than the rowing stroke itself. It simultaneously loads the pectoralis and shoulder girdle on the implant side, which is the least favorable vector for a healing pocket and freshly fixated leads. Logistic mitigation (dolly, partner launch) is reasonable and not overcautious.

Rowing and Heavy Lifting After Transvenous LBBAP Pacemaker: A Clinical Reassessment

Cardiac Electrophysiology · April 26, 2026

Clinical context. A patient previously implanted with an Abbott Aveir VR leadless pacemaker (May 2024) for complete heart block, with ~97% RV pacing burden, has undergone upgrade to a dual-chamber transvenous system with Left Bundle Branch Area Pacing (LBBAP) performed by Dr. Parikshit S. Sharma. Activity restrictions must now be re-evaluated against the new anatomy and hardware.

1. Why a Generic Restriction Template Does Not Fit Modern LBBAP Systems

A widely circulated patient-facing analysis flagged three principal risks for elderly patients with transvenous pacemakers performing rowing and lifting a 32-pound (14.5 kg) boat: pacemaker lead stress with clavicular pinch, subclavian vein thrombosis, and chest wall stress with pocket-related complications. The framework is reasonable in the aggregate but is built on a medial subclavian puncture, RV-apex-lead mental model that no longer represents contemporary implant practice — and certainly does not represent this patient's current configuration.

The implanted system is a dual-chamber transvenous pacemaker with:

Left prepectoral pocket fashioned medial to the deltopectoral groove
Axillary vein access ×2 using double-guidewire technique through two 7F peel-away introducers
LBBAP ventricular lead deployed via C315 sheath, fixated 1–2 cm distal to the His bundle region into the interventricular septum, with non-selective LBB capture morphology (rsR' in V1, S waves in I and V6, paced QRSd 110 ms from baseline LBBB QRSd of 212 ms, V6–V1 interval 70 ms, LVAT 67 ms)
Atrial lead (Medtronic 5076) fixated in the right atrial appendage
Both leads anchored to pectoral muscle with 2-0 Ethibond suture sleeves

Reframing the original concerns against this anatomy — rather than against a generic transvenous template — produces a meaningfully different risk profile.

2. Reassessing Each Original Concern

Clavicular pinch / subclavian crush syndrome

This mechanism is specific to medial subclavian puncture, where the lead traverses the costoclavicular ligament and is compressed between the clavicle and first rib during shoulder girdle motion. The implant note documents axillary venous access, which enters the vein lateral to that ligament. The dominant crush vector is therefore largely bypassed. The lead still passes through the shoulder soft tissues, so vigorous repetitive overhead motion is not without consequence — but the classical insulation-failure-by-bony-compression pathway does not apply with the same weight as in older medial-subclavian implants.

Subclavian / axillary vein thrombosis

This concern is genuinely re-introduced by the upgrade. Two transvenous leads now occupy the axillary–subclavian–brachiocephalic venous corridor. Repetitive ipsilateral arm exertion — and rowing 7+ km sessions qualifies — raises the question of effort-related upper-extremity DVT (Paget-Schroetter physiology) layered on top of foreign-body-related thrombotic risk. This is not a reason to forbid rowing categorically, but it is a reason to monitor for arm swelling, supraclavicular fullness, or new collateral venous patterns on the chest wall.

Pectoral pocket and chest wall stress

A real concern again. The pocket is a fresh prepectoral cavity closed in layers, with a generator and two anchored leads. Pectoralis contraction loads the pocket directly. The 32-pound boat lift, especially as an overhead or front-loaded carry on the implant side, produces simultaneous loading of the pectoralis and shoulder girdle — the least favorable vector during the pocket healing window.

LBBAP-specific lead maturation

The original analysis did not address this because it predated the LBBAP era in its framing. Septal LBBAP leads, anchored by rapid-rotation helix into the interventricular septum, carry a documented early-phase macro-dislodgement and micro-dislodgement risk that is higher than mature, scar-encased RV apical leads. Threshold drift, R-wave amplitude change, and impedance shift on serial interrogation are the relevant surveillance parameters. The first 6–8 weeks dominate the risk curve.

3. Pacing Dependence Considerations

The patient's pre-upgrade RV pacing burden was approximately 97%, consistent with high-grade atrioventricular block and minimal underlying escape rhythm. Post-LBBAP, ventricular pacing burden is expected to remain high, but with physiologic conduction system recruitment rather than RV-apex-driven dyssynchrony. This shift is the therapeutic rationale for the upgrade. From an activity-safety standpoint, however, the implication is unchanged: acute loss of capture from lead dislodgement remains a hemodynamic emergency in a pacing-dependent patient. Capture margin on serial interrogation — programmed output relative to threshold — is the single most actionable parameter for activity clearance.

4. The Two Activities, Reassessed

The 32-pound boat lift

This is the more acute concern of the two. The combination of overhead/front-loaded weight on the implant side, simultaneous pectoral and deltoid recruitment, and Valsalva-induced hemodynamic swing in a patient with documented progressive LV remodeling (declining EF, LA dilation, chronically elevated hs-TnT) creates an unfavorable composite. Logistic mitigation is the correct answer: a boat dolly or cart, partner-assisted launch, or shore-side handling that removes the overhead carry from the implant side. This is not overcautious; it is appropriate engineering of the exposure.

Rowing in a single

More nuanced. The catch phase loads the pectoralis bilaterally and symmetrically, with peak forces that are submaximal compared to a heavy lift. The dominant concern is cumulative ipsilateral arm work over long sessions (7+ km) and its venous implications, plus the generic — not pacemaker-specific — risks of capsize, cold-water shock, and isolated incapacitation in an unstable shell. Timing relative to implant date dominates the early decision; lead stability on interrogation dominates the long-term decision.

5. The Questions That Determine the Real Answer

Time since implant. Inside the 6–8 week pocket and lead maturation window, both activities should be deferred. Outside that window, the calculus shifts substantially.
LBBAP lead stability. Threshold trend, R-wave amplitude trend, and impedance trend at the 2-week, 6-week, and 3-month interrogations. Stable parameters are reassuring; drift is not.
Capture margin programming. Programmed output relative to current threshold determines tolerance for any acute threshold rise during exertion.
Venous surveillance. Subjective monitoring for ipsilateral arm swelling, dilated chest wall collaterals, or supraclavicular fullness, particularly given two leads in the axillary–subclavian system and high-volume ipsilateral arm work.
Underlying cardiac substrate. Pre-upgrade serial echo data showing progressive LV remodeling and elevated hs-TnT remains relevant independent of the device — the substrate, not the hardware, may be the more important governor of high-intensity endurance exertion.

6. Bottom Line

For a leadless device, most of the classical transvenous restrictions are anatomically inapplicable. For the current dual-chamber transvenous LBBAP system, most of those restrictions become applicable again — but with two important modulators: axillary access mitigates the classical clavicular pinch mechanism, and septal LBBAP lead maturation introduces a specific early-phase concern that the older literature does not capture.

The conversation worth having with the implanting electrophysiologist is not the categorical "can I exercise" — it is device-informed clearance keyed to specific activities, specific loads, and specific timing relative to implant date and interrogation parameters. The 32-pound lift on the implant side is the right thing to engineer around; the rowing question is the right thing to time against lead maturation.

Disclaimer. This article is intended for educational discussion among healthcare professionals and does not constitute individual medical advice. Clinical decisions must be made by the treating electrophysiologist in the context of the full patient record, current device interrogation data, and shared decision-making with the patient.